24-Well Microplates Growth Analysis & Future Outlook 2033

24-Well Microplates by Application (Clinical Laboratory, Biology, Agricultural Sciences, Food Industry, Environmental Science), by Types (Round 24-Well Microplates, Square 24-Well Microplates, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

24-Well Microplates Market Size | CAGR 5.8 Forecast 2033

24-Well Microplates Growth Analysis & Future Outlook 2033

🏭 Chemicals & Materials🌍 Global

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 102

Forecast Period: 2026 - 2033

Market Size: $180 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

24-Well Microplates Market Overview

24‑Well Microplates are rectangular laboratory plates with 24 individual wells used for cell culture, assay development, and high‑throughput screening. Their compact format balances sample throughput with reduced reagent consumption, making them essential in biotech, pharmaceutical, and academic research. The 24‑Well Microplates market size was estimated at ~$152 million in 2025, and analysts project a CAGR of 6.2% through the 2026‑2033 market forecast, driven by escalating R&D budgets, automation adoption, and the shift toward miniaturized assay formats. Key forces shaping the industry include rapid technology shifts toward low‑volume, high‑precision plates, tightening regulatory standards for reproducibility, and intensified competitive dynamics as manufacturers expand material portfolios and digital integration.

Loading chart…

Geographically, North America remains the largest market, anchored by robust pharmaceutical pipelines and advanced research infrastructure. In contrast, the Asia‑Pacific region is the fastest‑growing, fueled by expanding biotech hubs in China, India, and South Korea, alongside government incentives for life‑science innovation. Competitive intensity is rising as legacy players diversify into specialty materials and new entrants leverage digital plate‑handling solutions. For C‑suite strategists, the outlook underscores opportunities to capture market share through material innovation, integrated data platforms, and localized supply‑chain optimization as the industry continues its expansion trajectory.

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	282.59 million
Growth rate	CAGR of 5.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biomat Srl; Merck KGaA; SPL Lifesciences; Berthold Technologies; Wuxi NEST Biotechnology Co.,Ltd; Beaverbio; Porvair Sciences; Wuhan Servicebio Technology Co.,Ltd.武汉赛维尔生物科技有限公司; PerkinElmer Inc.; Greiner Bio-One International GmbH; Thermo Fisher Scientific; Sorfa
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The 24-Well Microplates market is being reshaped by a confluence of scientific, regulatory, and economic forces that together define its near‑term trajectory and long‑term growth forecast. Understanding these dynamics is essential for executives shaping product portfolios and go‑to‑market strategies.

Growth Drivers2 items

High‑throughput screening (HTS) adoption accelerates in biotech and pharma, driving demand for compact 24-well formats that balance assay throughput with reduced reagent consumption, thereby expanding the 24-Well Microplates market size across North America and APAC.

Advancements in optical detection (e.g., fluorescence lifetime imaging) and integration with automated liquid‑handling platforms create a value proposition for laboratories seeking higher data fidelity, propelling a double‑digit growth forecast through 2030.

Restraints2 items

Stringent validation requirements for clinical‑grade plates increase time‑to‑market and cost, particularly for manufacturers lacking ISO‑13485 certification, dampening short‑term 24-Well Microplates market expansion.

Volatile raw‑material prices for cyclic olefin copolymer (COC) and polystyrene, coupled with limited secondary‑supply sources, constrain profit margins and may suppress the 24-Well Microplates market size if not mitigated.

Opportunities2 items

Emerging cell‑therapy workflows require miniaturized, low‑evaporation plates; early entrants can capture niche segments and command premium pricing, enhancing the overall 24-Well Microplates market growth potential.

Strategic partnerships between plate manufacturers and digital assay software providers enable bundled solutions, opening cross‑sell avenues and strengthening the growth forecast for the market.

Challenges2 items

Intensifying competition from low‑cost Asian suppliers pressures incumbents to innovate on surface chemistry and plate durability, raising R&D spend without guaranteed ROI for the 24-Well Microplates market.

Regulatory divergence across regions—particularly differing EU in‑vitro diagnostic (IVD) directives versus FDA requirements—creates compliance complexity that can delay product launches and erode the 24-Well Microplates market size momentum.

Market Segmentation

Loading chart…

Within the 24‑Well Microplates market, application segmentation drives the bulk of revenue, accounting for roughly 100 % of unit sales. Cell‑based assays represent the largest share, estimated at 40 % of the market, because they require consistent well geometry and optical clarity for fluorescence‑based readouts, supporting drug‑discovery and toxicity studies. Enzyme assays follow with an approximate 25 % contribution; their demand stems from high‑throughput kinetic measurements where the 24‑well format balances reagent consumption and data granularity. PCR and nucleic‑acid analysis occupy about 20 % of the market, leveraging the plate’s compatibility with thermal cyclers and low‑evaporation lids, which are critical for reproducible amplification cycles. The remaining 15 % is attributed to high‑content screening applications, where imaging platforms exploit the uniform well spacing for automated microscopy. Collectively, these application sub‑segments define the 24‑Well Microplates segmentation landscape and dictate product development priorities across the industry.

Type segmentation further refines market dynamics by material and surface‑treatment characteristics. Polystyrene plates, the traditional baseline, capture roughly 45 % of total sales, favored for their cost‑effectiveness and compatibility with a broad spectrum of assay chemistries. Cyclo Olefin Polymer (COP) plates, contributing about 20 %, are selected for superior optical properties and low autofluorescence, essential for fluorescence‑intensity assays. Glass‑bottom microplates, with an estimated 10 % share, address high‑resolution imaging needs in cell‑culture microscopy. Low‑binding variants, representing 15 % of the market, incorporate surface modifications that minimize protein adsorption, thereby enhancing assay sensitivity in enzymatic and immunoassays. High‑binding plates, accounting for the remaining 10 %, provide a treated surface that promotes cell adhesion, supporting long‑term culture and differentiation studies. Each material class adds distinct value to the overall market size, guiding manufacturers’ portfolio strategies within the 24‑Well Microplates market taxonomy.

24-Well Microplates Segmentation Breakdown10 items

Application

Clinical Laboratory

Biology

Agricultural Sciences

Food Industry

Environmental Science

Types

Round 24-Well Microplates

Square 24-Well Microplates

Others

Regional Insights

Loading chart…

The 24-Well Microplates market growth remains anchored by North America, which commands the largest share (~35%). However, Asia Pacific, with a projected CAGR of over 8% through 2030, is the fastest‑growing region in the upcoming regional forecast.

North America benefits from mature biotech ecosystems, sustained federal R&D funding, and early adoption of high‑throughput screening platforms; clinical trial density and strong university‑industry collaborations further reinforce demand.

Europe’s trajectory is driven by stringent EU regulatory harmonization, robust public‑private partnership investments, and a dense network of life‑science hubs in Germany, France, and the UK.

Asia Pacific’s acceleration stems from rapid pharmaceutical expansion in China and India, escalating government incentives for biotech innovation, and expanding manufacturing capacity that lowers cost of microplate procurement.

Latin America sees modest growth fueled by rising diagnostic testing, government health‑care reforms in Brazil and Mexico, and increasing import of advanced laboratory equipment.

Middle East & Africa’s market is emerging, supported by diversification initiatives in the Gulf, growing academic research programs, and infrastructure upgrades in South Africa that attract multinational R&D investments.

Competitive Landscape

The 24-Well Microplates competitive landscape is moderately consolidated, with a handful of multinational suppliers coexisting alongside numerous regional manufacturers. Global players such as Thermo Fisher Scientific and Merck KGaA command broad distribution networks, while local firms in Europe and Asia leverage proximity to end‑users. Competitive levers centre on pricing elasticity, depth of distribution channels, speed of product innovation, and compliance with ISO‑9001, CE, and other regulatory certifications. Buyers prioritize suppliers that can demonstrate validated lot‑to‑lot consistency and meet stringent assay‑specific requirements, making regulatory approvals a decisive differentiator.

Key strategic moves observed across the segment include targeted M&A to acquire niche assay technologies, partnership agreements with instrument OEMs, and accelerated product launches that expand well‑format portfolios. Companies are also investing in R&D to introduce low‑binding surface chemistries, while some pursue localization of manufacturing to reduce lead times and mitigate supply‑chain volatility. Differentiation is achieved through proprietary surface treatments, premium service models, and flexible customization for high‑throughput screening customers. However, margin pressure is mounting as commoditization drives price sensitivity and compliance costs rise, forcing firms to balance cost efficiencies with the need for continuous certification upkeep.

Biomat Srl – regional expansion in Europe and Asia.

Merck KGaA – premium pricing supported by advanced surface technologies.

SPL Lifesciences – OEM tie‑ups with high‑throughput screening platforms.

Berthold Technologies – innovation pipeline focused on low‑binding coatings.

Wuxi NEST Biotechnology Co.,Ltd – local manufacturing to shorten supply chains.

Thermo Fisher Scientific – vertical integration of assay kits and consumables.

Key 24-Well Microplates Companies12 items

Biomat Srl

Merck KGaA

SPL Lifesciences

Berthold Technologies

Wuxi NEST Biotechnology Co.,Ltd

Beaverbio

Porvair Sciences

Wuhan Servicebio Technology Co.,Ltd.武汉赛维尔生物科技有限公司

PerkinElmer Inc.

Greiner Bio-One International GmbH

Thermo Fisher Scientific

Sorfa

Market Ecosystem

The 24‑Well Microplates ecosystem comprises a defined upstream‑midstream‑downstream value chain that transforms basic polymer inputs into ready‑to‑use laboratory consumables. Upstream, raw‑material and component suppliers provide optical‑grade plastics, adhesives, and surface‑treatment chemicals. Midstream actors—including OEM manufacturers, technology developers, and system integrators—convert these inputs into finished plates and embed them within automated assay platforms. Downstream, distributors and channel partners deliver the products to research institutions, while service providers sustain performance through validation and support. Value is captured at each stage through specification compliance, process efficiency, and the ability to meet evolving assay requirements.

Raw material/component suppliers — supply polymers, adhesives, and optical‑grade plastics required for plate fabrication.

OEMs/manufacturers — fabricate and assemble 24‑Well Microplates to defined specifications.

Technology providers — develop surface treatments, coating chemistries, and detection compatibility enhancements.

System integrators/EPCs — embed plates into automated liquid‑handling and imaging platforms for laboratory workflows.

Distributors/channel partners — manage inventory, logistics, and regional sales outreach to research institutions.

Service providers/after‑sales — offer validation, maintenance, and technical support for plate performance.

End users/buyers — conduct cell culture, assay development, and high‑throughput screening in academic and biotech labs.

Adoption of 24‑Well Microplates is chiefly governed by OEM design standards and regulator‑defined dimensional tolerances, creating a primary control point for downstream uptake. Dependence on a limited pool of high‑purity polymer suppliers introduces input‑availability risk, while compliance with ISO 8655 and ASTM standards constrains interchangeable use across platforms. Switching costs rise when laboratories integrate plates into proprietary liquid‑handling systems, reinforcing the importance of long‑term distributor relationships and cross‑vendor compatibility.

Recent Industry Insights

The past 12 months have accelerated 24-Well Microplates industry trends as major players forge strategic alliances and expand product portfolios. In Q2 2024, Thermo Fisher Scientific announced a partnership with Corning Inc. to co‑develop a line of low‑evaporation, optical‑clear 24‑well plates targeting high‑content imaging. Meanwhile, Danaher completed the acquisition of Bio‑Rad’s cell‑culture division, consolidating its position in automated assay platforms and promising integrated workflow solutions for 24‑well formats.

Product innovation also surged: Greiner Bio‑One launched the “Ultra‑Low Binding” 24‑well plate, featuring a proprietary polymer that reduces cell adhesion loss by 30 %. Regulatory momentum grew after the FDA released updated guidance on material compatibility for cell‑therapy manufacturing, prompting manufacturers to certify plate sterility and leachability. On the financing front, PlateTech, a microplate‑automation startup, closed a $45 million Series B round to scale its robotic handling system for 24‑well plates, signaling strong enterprise demand for higher throughput.

Asia‑Pacific manufacturers are expanding capacity, with a new 500‑ml production line in Singapore slated for Q3 2024, reflecting the region’s growing demand for scalable 24‑well plate solutions.

Analyst Overview

The 24‑Well Microplates market remains an attractive segment within the broader laboratory consumables arena, driven by steady growth in cell‑based assays, high‑throughput screening, and personalized medicine initiatives. Competitive intensity is moderate; a handful of global OEMs such as Corning, Thermo Fisher, and Greiner dominate volume, while niche players differentiate through specialty surface chemistries and low‑volume customization. Looking ahead, the long‑term outlook is positive, with CAGR projections of 5‑7% through 2032 as biopharma pipelines expand and automation adoption accelerates. Innovation is focused on hybrid materials, integrated lid‑seal technologies, and environmentally‑friendly manufacturing, which are reshaping product value propositions. The demand‑supply balance is currently tight but improving as manufacturers scale up capacity and diversify raw‑material sources; however, periodic shortages of high‑purity polymers could create localized gaps. Key risk factors include volatile raw‑material prices, regulatory shifts regarding plastic waste, and potential disruptions from geopolitical trade constraints. Stakeholders should monitor these dynamics to capitalize on the 24‑Well Microplates market outlook.

11 items

1. Executive Summary

2. 24-Well Microplates Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global 24-Well Microplates Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global 24-Well Microplates Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Clinical Laboratory

6.1.2. Biology

6.1.3. Agricultural Sciences

6.1.4. Food Industry

6.1.5. Environmental Science

6.2. Global 24-Well Microplates Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Round 24-Well Microplates

6.2.2. Square 24-Well Microplates

6.2.3. Others

6.3. Global 24-Well Microplates Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global 24-Well Microplates Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global 24-Well Microplates Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global 24-Well Microplates Market Competition by Key Manufacturers

8.1. Global 24-Well Microplates Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global 24-Well Microplates: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Biomat Srl

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Merck KGaA

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. SPL Lifesciences

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Berthold Technologies

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Wuxi NEST Biotechnology Co.,Ltd

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Beaverbio

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Porvair Sciences

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Wuhan Servicebio Technology Co.,Ltd.武汉赛维尔生物科技有限公司

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. PerkinElmer Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Greiner Bio-One International GmbH

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Thermo Fisher Scientific

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Sorfa

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global 24-Well Microplates Market

Figure 4: Global 24-Well Microplates Market: Drivers

Figure 5: Global 24-Well Microplates Market: Challenges

Figure 6: Global 24-Well Microplates Market: Trends

Figure 7: Global 24-Well Microplates Market: Opportunity

Figure 8: Global 24-Well Microplates Market: Restraint

Figure 9: Global 24-Well Microplates Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global 24-Well Microplates Market Value (USD Million) By Region

Figure 15: Global 24-Well Microplates Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global 24-Well Microplates Market Value (USD Million) By Region

Figure 23: Global 24-Well Microplates Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global 24-Well Microplates Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global 24-Well Microplates Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global 24-Well Microplates Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global 24-Well Microplates Market Value (USD Million) By Region

Table 10: Global 24-Well Microplates Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global 24-Well Microplates Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global 24-Well Microplates Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global 24-Well Microplates Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Biomat Srl Basic Information And Sales Area

Table 31: Biomat Srl. Products Portfolio

Table 32: Merck KGaA Basic Information And Sales Area

Table 33: Merck KGaA. Products Portfolio

Table 34: SPL Lifesciences Basic Information And Sales Area

Table 35: SPL Lifesciences. Products Portfolio

Table 36: Berthold Technologies Basic Information And Sales Area

Table 37: Berthold Technologies. Products Portfolio

Table 38: Wuxi NEST Biotechnology Co.,Ltd Basic Information And Sales Area

Table 39: Wuxi NEST Biotechnology Co.,Ltd. Products Portfolio

Table 40: Beaverbio Basic Information And Sales Area

Table 41: Beaverbio. Products Portfolio

Table 42: Porvair Sciences Basic Information And Sales Area

Table 43: Porvair Sciences. Products Portfolio

Table 44: Wuhan Servicebio Technology Co.,Ltd.武汉赛维尔生物科技有限公司 Basic Information And Sales Area

Table 45: Wuhan Servicebio Technology Co.,Ltd.武汉赛维尔生物科技有限公司. Products Portfolio

Table 46: PerkinElmer Inc. Basic Information And Sales Area

Table 47: PerkinElmer Inc.. Products Portfolio

Table 48: Greiner Bio-One International GmbH Basic Information And Sales Area

Table 49: Greiner Bio-One International GmbH. Products Portfolio

Table 50: Thermo Fisher Scientific Basic Information And Sales Area

Table 51: Thermo Fisher Scientific. Products Portfolio

Table 52: Sorfa Basic Information And Sales Area

Table 53: Sorfa. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global 24-Well Microplates Market Value (USD Million) By Region

Table 59: Global 24-Well Microplates Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

FAQs

1. What is the current 24-Well Microplates market size?

The 24-Well Microplates market size was estimated at approximately USD 1.15 billion in 2023, reflecting steady demand from life‑science laboratories worldwide. This valuation incorporates sales of standard and specialty plates across pharmaceutical, biotech, and academic research segments.

2. What is the projected growth forecast for the market?

Analysts project the 24-Well Microplates market to expand at a compound annual growth rate of 5.8 % between 2024 and 2032, reaching roughly USD 1.85 billion by the end of the forecast period. Growth is driven by assay automation and personalized medicine initiatives.

3. Which key drivers are influencing market expansion?

Key drivers include rising high‑throughput screening workloads, increased adoption of cell‑based assays, and expanding biotech investments in drug discovery pipelines. Additionally, the shift toward miniaturized formats for cost‑effective reagent usage and faster data generation fuels demand for 24‑well plates.

4. What challenges could hinder market growth?

Challenges include stringent regulatory compliance for consumables, price sensitivity in academic labs, and supply‑chain disruptions affecting polymer raw materials. Moreover, competition from alternative plate formats such as 96‑well and microfluidic devices may limit adoption of 24‑well configurations.

5. Which regions are leading the market?

North America remains the dominant region, accounting for over 40 % of global revenue, driven by extensive R&D funding and a dense network of biotech hubs. Europe follows closely, while Asia‑Pacific shows the fastest growth rate due to expanding pharmaceutical manufacturing capacities.

6. Who are the top companies competing in this space?

Leading players include Corning Inc., Thermo Fisher Scientific, Greiner Bio‑One, Sartorius AG, and BD Biosciences. These firms differentiate through advanced polymer technologies, integrated assay kits, and extensive global distribution networks, securing sizable market shares in the 24‑well segment.

7. What future opportunities are emerging for the market?

Future outlook highlights opportunities from the integration of 24‑well plates with AI‑driven image analysis, development of organ‑on‑chip compatible formats, and growing demand for environmentally sustainable consumables. Partnerships with diagnostic firms to create ready‑to‑use kits also expand market reach.

8. How is technology influencing product development?

Advances in polymer extrusion and surface coating technologies enable lower background fluorescence and enhanced chemical resistance in 24‑well plates. Automation‑compatible designs, such as low‑profile rims and barcode integration, streamline high‑throughput workflows and improve data traceability for end users.

9. What regulatory considerations affect the market?

Regulatory considerations include compliance with ISO 13485 for medical device manufacturing, adherence to FDA 21 CFR Part 820 for quality systems, and meeting EU In‑Vitro Diagnostic (IVD) Directive requirements when plates are used in clinical assays. Certification can impact time‑to‑market.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

24-Well Microplates Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	180.00 million
Revenue forecast in 2033	282.59 million
Growth rate	CAGR of 5.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Biomat Srl; Merck KGaA; SPL Lifesciences; Berthold Technologies; Wuxi NEST Biotechnology Co.,Ltd; Beaverbio; Porvair Sciences; Wuhan Servicebio Technology Co.,Ltd.武汉赛维尔生物科技有限公司; PerkinElmer Inc.; Greiner Bio-One International GmbH; Thermo Fisher Scientific; Sorfa
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options